MARKET

CMPS

CMPS

Compass Pathways Plc
NASDAQ
9.65
-0.26
-2.62%
After Hours: 9.68 +0.03 +0.31% 19:59 05/11 EDT
OPEN
9.91
PREV CLOSE
9.91
HIGH
9.97
LOW
9.55
VOLUME
2.48M
TURNOVER
--
52 WEEK HIGH
10.21
52 WEEK LOW
2.250
MARKET CAP
1.30B
P/E (TTM)
-3.1345
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CMPS last week (0504-0508)?
Weekly Report · 1d ago
Earnings week ahead: BABA, CSCO, PLUG, AMAT, JD, and more
Seeking Alpha · 1d ago
A Look At COMPASS Pathways (CMPS) Valuation After Phase 3 COMP005 Success In Treatment Resistant Depression
Simply Wall St · 2d ago
EXE, IP, ESPR, CMPS, TNXP Trending With Analysts
TipRanks · 3d ago
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Benzinga · 3d ago
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
TipRanks · 4d ago
Compass Pathways to report Q1 results, hosts conference call
PUBT · 6d ago
Compass Pathways grants 125,335 inducement stock options at $9.01 per share
PUBT · 6d ago
More
About CMPS
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.

Webull offers Compass Pathways PLC (ADR) stock information, including NASDAQ: CMPS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMPS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMPS stock methods without spending real money on the virtual paper trading platform.